Anxiety Disorders

  • Edmond H. Pi
  • George M. Simpson


Today, because of the rapid changes, competition, and constant demands for higher achievement of contemporary society, it is inevitable that people will experience different degrees of anxiety. Indeed, anxiety is now the most prevalent psychological symptom. In general, anxiety refers to a subjective state of inner distress, such as apprehension, nervousness, or uneasiness related to threats that are vague, internal, and unknown. In contrast, fear refers to a response related to threats that are specific, external, and known real-life circumstances. Both anxiety and fear can be manifested in similar somatic symptoms or in signs of hyperactivity of the autonomic nervous system.


Anxiety Disorder Social Phobia Panic Disorder Posttraumatic Stress Disorder Panic Attack 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahlquist, R. P. (1948). A study of the adrenotropic receptors. American Journal of Physiology, 153, 586.PubMedGoogle Scholar
  2. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders ( 3rd ed. ). Washington, DC: Author.Google Scholar
  3. Beard, G. M. (1869). Neurasthenia or nervous exhaustion. Boston Medical and Surgical Journal, 3, 217–225.Google Scholar
  4. Braestrup, C., & Nielsen, M. (1982). Anxiety. Lancet, 2, 1030–1034.PubMedCrossRefGoogle Scholar
  5. Bueno, J. A., Sabanes, F., Gascon, J., Casto, C., & Salamero, M. (1984). Dexamethasone suppression test in patients with panic disorder and secondary depression. Archives of General Psychiatry, 41, 723–724.PubMedCrossRefGoogle Scholar
  6. Burstein, A. (1984). Treatment of post-traumatic stress disorder with imipramine. Psychosomatics, 25, 681–688.PubMedCrossRefGoogle Scholar
  7. Carr, D. J., & Sheehan, D. V. (1984). Panic anxiety: A new biological model. Journal of Clinical Psychiatry, 45, 323–330.PubMedGoogle Scholar
  8. Charney, D. S., Heninger, G. R., & Breier, A. (1984). Noradrenergic function in panic anxiety: Effects of Yohimbine in healthy subjects and patients with agoraphobic and panic disorders. Archives of General Psychiatry 41, 751–763.PubMedCrossRefGoogle Scholar
  9. Clancy, J., Noyes, R., Hoenck, P. R., & Sylmen, D. J. (1978). Secondary depression in anxiety neurosis. Journal of Nervous and Mental Disease, 166, 846–850.PubMedCrossRefGoogle Scholar
  10. Claycomb, J. B. (1983). Endogenous anxiety: Implications for nosology and treatment. Journal of Clinical Psychiatry, 44 (8 sec. 2), 19–22.PubMedGoogle Scholar
  11. Cohen, M. E., & White, P. D. (1950). Life situations, emotions and neurocirculatory asthenia (anxiety neurosis, neuroasthenia, effort syndrome). Association for Research and Mental Disease, 29, 832–869.Google Scholar
  12. Coryell, W. (1981). Obsessive-compulsive disorder and primary unipolar depression: Comparisons of background, family history, course and mortality. Journal of Nervous and Mental Disease, 169, 220–224.PubMedCrossRefGoogle Scholar
  13. Coryell, W., Noyes, R., & Clancy, N. (1982). Excess mortality in panic disorder. Archives of General Psychiatry, 39, 701–703.PubMedCrossRefGoogle Scholar
  14. Crowe, R. R., Noyes, R., Paul, D. L., & Sylmen, D. (1983). A family study of panic disorder. Archives of General Psychiatry, 40, 1065–1069.PubMedCrossRefGoogle Scholar
  15. Curtis, G. C., Cameron, O. G., & Neese, R. M. (1982). The dexamethasone suppression test in panic disorder and agoraphobia. American Journal of Psychiatry, 139, 1043–1046.PubMedGoogle Scholar
  16. DaCosta, J. M. (1871). On irritable heart, a clinic form of functional cardiac disorder and its consequences. American Journal of Medical Sciences, 61, 17.Google Scholar
  17. Duffy, E. (1957). The psychological significance of the concept of “arousal” or “activation.” Psychological Review, 64, 844–914.CrossRefGoogle Scholar
  18. Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983). Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. Physiological Review, 63, 844–914.Google Scholar
  19. Freud, S. (1960). The justification for detaching from neurasthenia a particular syndrome: The anxiety- neurosis. In E. Jones (Ed.), Sigmund Freud: Collected Papers (Vol. 1 ). New York: Basic Books. (Original work published 1894 ).Google Scholar
  20. Friedman, M. J. (1981). Post-Vietnam syndrome: Recognition and management. Psychosomatics, 22, 931–943.PubMedGoogle Scholar
  21. Goodwin, D. W., & Guze, S. B. (1984a). Phobic disorder. In D. W. Goodwin & S. B. Guze, (Eds.), Psychiatric disorders. New York: Oxford University Press.Google Scholar
  22. Goodwin, D. W., & Guze, S. B. (1984b). Obsessive-compulsive disorder. In D. W. Goodwin & S. B. Guze, (Eds.), Psychiatric disorders. New York: Oxford University Press.Google Scholar
  23. Gorman, J. M., Fryer, A. F., Gliklich, J., King, D., & Klein, D. F. (1981). Effect of sodium lactate on patients with panic disorder and mitral valve prolapse. American Journal of Psychiatry, 138, 247–249.PubMedGoogle Scholar
  24. Greenblatt, D., & Shader, R. I. (1971). Meprobamate, a study of irrational drug use. American Journal of Psychiatry, 127, 1297.PubMedGoogle Scholar
  25. Harris, E. I., Noyes, R., Crowe, R. R., & Chaudhry, R. (1983). A family study of agoraphobia: Report of a pilot study. Archives of General Psychiatry, 40, 1051–1064.CrossRefGoogle Scholar
  26. Hartman, N., Kramer, R., Brown, W. T., & Devereux, R. B. (1982). Panic disorder in patients with mitral valve prolapse. American Journal of Psychiatry, 139, 669–670.PubMedGoogle Scholar
  27. Heiser, J. F., & Defrancisco, D. (1976). The treatment of pathological panic states with propranolol. American Journal of Psychiatry, 133, 1389–1394.PubMedGoogle Scholar
  28. Helzer, J. E., Robins, L. N., & Wish, E. (1979). Depression in Vietnam veterans and civilian controls. American Journal of Psychiatry, 136, 526–529.PubMedGoogle Scholar
  29. Hoehn-Saric, R. (1982). Neurotransmitters in anxiety. Archives of General Psychiatry, 39, 735–742.PubMedCrossRefGoogle Scholar
  30. Inouye, E. (1965). Similar and dissimilar manifestations of obsessive-compulsive neurosis in monozygotic twins. American Journal of Psychiatry, 121, 1171–1175.PubMedGoogle Scholar
  31. Insel, T. R., Murphy, D. L., Cohen, R. M., Alterman, I., Kilts, C., & Linnoila, M. (1983). Obsessive- compulsive disorder: A double blind trial of clomipramine and cloryline. Archives of General Psychiatry, 40, 605–612.PubMedCrossRefGoogle Scholar
  32. Insel, T. R., Ninan, P. T., Aloi, J., Jimerson, D. C., Skolnick, P., & Paul, S. M. (1984). A benzodiazepine receptor-mediated model of anxiety: Studies in non-human primates and clinical implications. Archives of General Psychiatry, 41, 741–750.PubMedCrossRefGoogle Scholar
  33. Kane, J. M., Woerner, M., Zeldis S., Kramer, R., & Saravey, S. (1981). Panic and phobic disorders in patients with mitral valve prolapse. In D. F. Klein & J. Rabkin (Eds.), Anxiety: New research and changing concepts. New York: Raven Press.Google Scholar
  34. Kathol, R. G., Noyes, R., Slymen, P. J., Crowe, R. R., Clancy, J., & Kerber, R. E. (1980). Propranolol in chronic anxiety disorders. Archives of General Psychiatry, 27, 1361–1365.CrossRefGoogle Scholar
  35. Kelly, D. H. W., & Walter, C. J. S. (1968). The relationship between clinical diagnosis and anxiety assessed by forearm blood flow and other measurements. British Journal of Psychiatry, 114, 611–626.PubMedCrossRefGoogle Scholar
  36. Kelly, D. H. W., Mitchell-Heggs, N., & Sherman, D. (1971). Anxiety and the effects of sodium lactate assessed clinically and physiologically. British Journal of Psychiatry, 119, 129–141.PubMedCrossRefGoogle Scholar
  37. Klein, D. F. (1964). Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia (Berlin), 5, 397–408.CrossRefGoogle Scholar
  38. Klein, D. F. (1980). Importance of psychiatric diagnosis in prediction of clinical drug effects. Archives of General Psychiatry, 17, 63–72.Google Scholar
  39. Lader, M. H., Gelder, M. G., & Marks, I. M. (1967). Palmar skin-conductance measures as predictors of response to desensitization. Journal of Psychosomatic Research, 11, 283–290.PubMedCrossRefGoogle Scholar
  40. Leckman, J. F., Weissman, M. M., Merikangas, R., Pauls, D. L., & Prusoff, B. A. (1983). Panic disorder and depression: Increased risk of depression alcoholism, panic and phobia disorders in families of depressed probands with panic disorders. Archives of General Psychiatry, 40, 1055–1060.PubMedCrossRefGoogle Scholar
  41. Liebowitz, M. R., Fryer, A. J., Gorman, J. M., Dillon, D., Appleby, I. L., Levy, G., Anderson, S., Levitt, M., Palij, M., Davies, S. O., & Klein, N. F. (1984). Lactate provocation of panic attacks: I. Clinical and behavioral findings. Archives of General Psychiatry, 41, 764–770.PubMedCrossRefGoogle Scholar
  42. Linko, E. (1950). Lactic acid response to muscular exercise in neurocirculatory asthenia. Annales Medicinae lnternae Fenniae, 39, 161–176.Google Scholar
  43. Marks, I., Lader, M. (1973). Anxiety states (anxiety neurosis): A review. Journal of Nervous and Mental Disease, 156, 3–18.PubMedCrossRefGoogle Scholar
  44. Marks, I. M., Stern, R. S., & Mewson, D. (1980). Clomipramine and exposure for obsessive-compulsive rituals: I and II. British Journal of Psychiatry, 136, 1-25, 161–166.Google Scholar
  45. Mathew, R. J., Ho, B. T., Kralik, P., Taylor, D., Semchuck, K., Weiman, M., & Cloghorn, J. L. (1980). Catechol-o-methyltransference and catecholamines in anxiety and relaxation. Psychiatry Research, 3, 85–91.PubMedCrossRefGoogle Scholar
  46. Matuzas, W., & Glass, R. M. (1983). Treatment of agoraphobia and panic attacks. Archives of General Psychiatry, 40, 220–222.PubMedCrossRefGoogle Scholar
  47. Mcguffin, P., & Mawson, D. (1980). Obsessive-compulsive neurosis: Two identical twin pairs. British Journal of Psychiatry, 137, 285–287.PubMedCrossRefGoogle Scholar
  48. Mohler, H., & Okada, T. (1977). Benzodiazepine receptor: Demonstration in the central nervous system. Science, 198, 849–851.PubMedCrossRefGoogle Scholar
  49. Munjack, D. J., & Moss, H. B. (1981). Affective disorders and alcoholism in families of agoraphobia. Archives of General Psychiatry, 38, 869–874.PubMedCrossRefGoogle Scholar
  50. Neese, R. M., Cameron, O. G., Curtis G. C., McCann, D. S., & Humber-Smith, M. J. (1984). Adrenergic function in patients with panic anxiety. Archives of General Psychiatry, 41, 771–776.CrossRefGoogle Scholar
  51. Noyes, R., & Clancy, J. (1976). Anxiety Neurosis: A 5-year follow-up. Journal of Nervous and Mental Disease, 162, 200–205.PubMedCrossRefGoogle Scholar
  52. Noyes, R., Clancy, J., Crowe, R., Hoenk, P. R., & Slymen, D. J. (1978). The familial prevalence of anxiety neurosis. Archives of General Psychiatry, 35, 1957–1059.CrossRefGoogle Scholar
  53. Noyes, R., Jr., Clancy, J., Hoenk, P. R., & Slymen, D. J. (1980). The prognosis of anxiety neurosis. Archives of General Psychiatry, 37, 173–178.PubMedCrossRefGoogle Scholar
  54. Pauls, D. L., Paucher, K. D., Crowe, R. R., & Noyes, R. (1980). A genetic study of panic disorder pedigrees. American Journal of Human Genetics, 32, 639–644.PubMedGoogle Scholar
  55. Pi, E. H., & Simpson G. M. (1982). The use and misuse of benzodiazepines: An update. The Journal of Continuing Education for the Family Physician, 16, 102–106.Google Scholar
  56. Pitts, F. N., & McClure, J. N. (1967). Lactate metabolism in anxiety neurosis. New England Journal of Medicine, 227, 1329–1336.CrossRefGoogle Scholar
  57. Quitkin, F. M., Rifkin, A., Kaplan, J., & Klein, D. F. (1972). Phobic anxiety syndrome complicated by drug dependence and addiction. Archives of General Psychiatry, 27, 159–162.PubMedCrossRefGoogle Scholar
  58. Rakel, R. E. (1981). Differential diagnosis of anxiety. Psychiatric Annals, 77 (supplement), 11–14.Google Scholar
  59. Raymond, R. C., Pauls, D. L. Slymen, D. J., & Noyes, R. (1980). A family study of anxiety neurosis. Archives of General Psychiatry, 37, 77–79.Google Scholar
  60. Redmond, D. E., Jr., Huang, Y. H. (1979). New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sciences, 25, 2149–2162.PubMedCrossRefGoogle Scholar
  61. Rickels, J. (1978). Use of antianxiety agents in anxious outpatients. Psychopharmacology, 58, 1–18.PubMedCrossRefGoogle Scholar
  62. Rifkin, A., Klein, D. F., Dillon, D., & Levitt, M. (1981). Blockage by imipramine or desipramine of panic induced by sodium lactate. American Journal of Psychiatry, 138, 676–677.PubMedGoogle Scholar
  63. Roth, M., Mountjoy, C., & Caetano, D. (1982). Further investigations into the relationship between depressive disorders and anxiety states. Pharmacopsychiatria, 15 (4), 135–141.PubMedCrossRefGoogle Scholar
  64. Schapira, K., Roth, M., Kerr, T. A., & Gurney, C. (1972). The prognosis of affective disorders: The differentiation of anxiety states from depressive illnesses. British Journal of Psychiatry, 121, 175–181.PubMedCrossRefGoogle Scholar
  65. Sheenan, D. V. (1982a). Current perspectives in the treatment of panic and phobic disorders. Drug Therapy, 12, 49–63.Google Scholar
  66. Sheenan, D. V. (1982b). Panic attacks and phobias. New England Journal of Medicine, 307, 156–158.CrossRefGoogle Scholar
  67. Sheenan, D. V., Ballenger, J., & Jacobson, G. (1980). Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Archives of General Psychiatry, 37, 51–59.CrossRefGoogle Scholar
  68. Sierles, F. S., Chen, J. J., McFarland, R. E., & Taylor, M. A. (1983). Post-traumafic stress disorder and concurrent psychiatric illness: A preliminary report. American Journal of Psychiatry, 140, 1177–1179.PubMedGoogle Scholar
  69. Slater, E., & Shields, J. (1964). Genetical aspects of anxiety. In M. H. Loder (Ed.), Studies of anxiety. Ashford Kent: Headley.Google Scholar
  70. Squires, RF., & Braestrup, C. (1977). Benzodiazepine receptors in rat brain, Nature, 266, 732–734.PubMedCrossRefGoogle Scholar
  71. Tallman, J. F., Paul, S. M., Skolnick, P., & Gallager, D. W. (1980). Receptors for the age of anxiety: Pharmacology of the benzodiazepines. Science, 207, 274–281.PubMedCrossRefGoogle Scholar
  72. Thoren, P., Asberg, M., Cronholm, J., Jornestedt, L., & Traskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder: A controlled clinical trial. Archives of General Psychiatry, 37, 1281–1289.PubMedCrossRefGoogle Scholar
  73. Uhlenhuth, E. H., Baiter, M. J., Mellinger, G. D., Cisin, I. H., & Clinthorne, J. (1983). Symptom checklist syndrome in the general population. Archives of General Psychiatry, 40, 1167–1173.PubMedCrossRefGoogle Scholar
  74. Ursano, R. J. (1981). The Vietnam era prisoners of war: Precaptivity personality and the development of psychiatric illness. American Journal of Psychiatry, 138, 315–318.PubMedGoogle Scholar
  75. Van Putten, T., & Yager, J. (1984). Post-traumatic stress disorders. Emerging from the rhetoric. Archives of General Psychiatry, 41, 411–413.PubMedCrossRefGoogle Scholar
  76. VanValkenburg, C., Winokur, G., Behar, D., & Lowry, M. (1984). Depressed women with panic attacks. Journal of Clinical Psychiatry, 45, 367–369.Google Scholar
  77. Weissman, M. M., Myers, J. K., & Harding, P. S. (1978). Psychiatric disorders in a U.S. urban community. American Journal of Psychiatry, 135, 459–462.PubMedGoogle Scholar
  78. Westphal, C. (1871). Die Agoraphobie: Eine neuropathische Erscheinung. Archives fur Psychiatrie und Nervenkrrankheiten, 3, 138–171.CrossRefGoogle Scholar
  79. Wheeler, E. D., White P. D., Reid, E. W., & Cohen, M. E. (1950). Neurocirculatory asthenia (anxiety neurosis, effort syndrome, neuroasthenia). Journal of the American Medical Association, 142, 878–889.PubMedCrossRefGoogle Scholar
  80. Wikler, A. (1968). Diagnosis and treatment of drug dependence of the barbiturate type. American Journal of Psychiatry, 125, 758–765.PubMedGoogle Scholar
  81. Yaryura-Tobias, J. A., Nezirogul, F., & Bergman, L. (1976). Chlorimipramine in obsessive-compulsive neurosis: An organic approach. Current Therapeutic Research, 20, 541–548.Google Scholar
  82. Zitrin, J. M., Klein, D. F., & Woerner, M. G. (1980). Treatment of agoraphobic with group exposure in vivo and imipramine. Archives of General Psychiatry, 37, 63–72.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Edmond H. Pi
    • 1
  • George M. Simpson
    • 2
  1. 1.Department of PsychiatryUniversity of Southern California, School of MedicineLos AngelesUSA
  2. 2.Department of PsychiatryThe Medical College of Pennsylvania at EPPIPhiladelphiaUSA

Personalised recommendations